Skip to main content
Log in

Comparison of the Pharmacological Effects of Dimeric Dipeptide Nerve Growth Factor Mimetic GK-2 and Mexidol on the Model of Ischemic Stroke in Rats

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

We compared the effects of GK-2 (dimeric dipeptide mimetic of nerve growth factor) and Mexidol (standard preparation for the therapy of stroke) on rat model of transient occlusion of the middle cerebral artery. GK-2 and Mexidol were administered intraperitoneally in the most active doses (1 and 100 mg/kg, respectively) 6 h after surgery and then once a day for 6 days. The preparations reduced the volume of cerebral infarction (by 60 and 30%, respectively). At the same time, GK-2 had a pronounced and statistically more reliable effect in a dose that is lower by two orders of magnitude. In addition, GK-2 significantly reduced the neurological deficit in the limb placement test, while Mexidol was ineffective in this test.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Antipova TA, Gudasheva TA, Seredenin SB. In vitro study of neuroprotective properties of GK-2, a new original nerve growth factor mimetic. Bull. Exp. Biol. Med. 2011;150(5):607-609.

  2. Voronina TA. Mexidol: the main neuropsychotropic effects and mechanism of action. Farmateka 2009;(6):35-38. Russian.

    Google Scholar 

  3. Gudasheva TA, Antipova TA, Seredenin SB. Novel low-molecular-weight mimetics of the nerve growth factor. Dokl. Biochem. Biophysics 2010;434(1):262-265.

    CAS  Google Scholar 

  4. Seredenin SB, Gudasheva TA. The development of a pharmacologically active low-molecular mimetic of the nerve growth factor. Zh. Nevrol. Psikhiatr. 2015;115(6-1):63-70. Russian.

    Article  CAS  Google Scholar 

  5. Yasnetsov VV, Voronina TA. Effect of Semax and Mexidol on brain ischemia models in rats. Eksp. Klin. Farmakol. 2009;72(1):68-70. Russian.

    CAS  Google Scholar 

  6. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986;17(6):1304-1308.

    Article  CAS  PubMed  Google Scholar 

  7. Gudasheva TA, Povarnina PY, Antipova TA, Firsova YN, Konstantinopolsky MA, Seredenin SB. Dimeric dipeptide mimetics of the nerve growth factor Loop 4 and Loop 1 activate TRKA with different patterns of intracellular signal transduction. J. Biomed. Sci. 2015;22:106. doi: https://doi.org/10.1186/s12929-015-0198-z.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Hassanzadeh P, Arbabi E, Atyabi F, Dinarvand R. Nerve growth factor-carbon nanotube complex exerts prolonged protective effects in an in vitro model of ischemic stroke. Life Sci. 2016. Dec 2. pii: S0024-3205(16):30681-6. doi: 10.1016/j.lfs.2016.11.029.

  9. Jiang H, Tian S, Zeng Y, Shi J. Nerve growth factor inhibits Gd(3+)-sensitive calcium influx and reduces chemical anoxic neuronal death. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2008;28(4):379-382.

    Article  CAS  PubMed  Google Scholar 

  10. Jolkkonen J, Puurunen K, Rantakömi S, Härkönen A, Haapalinna A, Sivenius J. Behavioral effects of the alpha(2)-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats. Eur. J. Pharmacol. 2000;400(2-3):211-219.

    Article  CAS  PubMed  Google Scholar 

  11. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20(1):84-91.

    Article  CAS  PubMed  Google Scholar 

  12. Oliveira SL, Pillat MM, Cheffer A, Lameu C, Schwindt TT, Ulrich H. Functions of neurotrophins and growth factors in neurogenesis and brain repair. Cytometry A. 2013 Vol. 83(1):76-89.

    Article  PubMed  Google Scholar 

  13. Park JH, Kang SS, Kim JY, Tchah H. Nerve growth factor attenuates apoptosis and inflammation in the diabetic cornea. Invest. Ophthalmol. Vis. Sci. 2016;57(15):6767-6775.

    Article  PubMed  Google Scholar 

  14. Yang JP, Liu HJ, Yang H, Feng PY. Therapeutic time window for the neuroprotective effects of NGF when administered after focal cerebral ischemia. Neurol. Sci. 2011;32(3):433-441.

    Article  PubMed  Google Scholar 

  15. Zhu W, Cheng S, Xu G, Ma M, Zhou Z, Liu D, Liu X. Intranasal nerve growth factor enhances striatal neurogenesis in adult rats with focal cerebral ischemia. Drug. Deliv. 2011;18(5):338-343.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Yu. Povarnina.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 164, No. 8, pp. 201-204, August, 2017

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Povarnina, P.Y., Volkova, A.A., Gudasheva, T.A. et al. Comparison of the Pharmacological Effects of Dimeric Dipeptide Nerve Growth Factor Mimetic GK-2 and Mexidol on the Model of Ischemic Stroke in Rats. Bull Exp Biol Med 164, 173–176 (2017). https://doi.org/10.1007/s10517-017-3951-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-017-3951-3

Key Words

Navigation